Integra LifeSciences Holdings Corporation (IART)
USD 20.06
(-7.9%)
USD 20.06
(-7.9%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 383.56 Million USD | 7.54% |
| 2022 | 391.1 Million USD | 15.21% |
| 2021 | 366.33 Million USD | 24.54% |
| 2020 | 267.93 Million USD | -6.38% |
| 2019 | 231.02 Million USD | 43.81% |
| 2018 | 241.03 Million USD | 114.52% |
| 2017 | 135.22 Million USD | -48.66% |
| 2016 | 231.72 Million USD | 38.17% |
| 2015 | 195.59 Million USD | 21.71% |
| 2014 | 172.24 Million USD | -12.85% |
| 2013 | 40.07 Million USD | -4.37% |
| 2012 | 116.45 Million USD | 29.23% |
| 2011 | 106.3 Million USD | -48.0% |
| 2010 | 139.64 Million USD | -0.04% |
| 2009 | 136.06 Million USD | 69.58% |
| 2008 | 79.33 Million USD | -10.83% |
| 2007 | 67.28 Million USD | 11.1% |
| 2006 | 58.74 Million USD | 17.37% |
| 2005 | 69.32 Million USD | 116.5% |
| 2004 | 36.37 Million USD | 21.14% |
| 2003 | 48.69 Million USD | 3.53% |
| 2002 | 25.8 Million USD | 72.91% |
| 2001 | 20.54 Million USD | 170.34% |
| 2000 | -13.2 Million USD | -46.32% |
| 1999 | -12.39 Million USD | 0.68% |
| 1998 | -16.6 Million USD | 23.96% |
| 1997 | -17.2 Million USD | -104.26% |
| 1996 | -7.5 Million USD | -163.95% |
| 1995 | -4.6 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -8.15 Million USD | -13.62% |
| 2024 Q1 | 38.96 Million USD | -9.18% |
| 2024 Q2 | 72.03 Million USD | -36.29% |
| 2023 Q4 | 86.4 Million USD | 147.72% |
| 2023 Q1 | 44.98 Million USD | -44.22% |
| 2023 FY | - USD | 7.54% |
| 2023 Q3 | 34.87 Million USD | 80.59% |
| 2023 Q2 | 19.31 Million USD | -57.07% |
| 2022 FY | - USD | 15.21% |
| 2022 Q3 | 100.42 Million USD | 7.5% |
| 2022 Q4 | 80.64 Million USD | -19.7% |
| 2022 Q2 | 93.42 Million USD | 15.77% |
| 2022 Q1 | 80.69 Million USD | 18.39% |
| 2021 Q1 | 41.85 Million USD | -30.96% |
| 2021 Q3 | 67.32 Million USD | 7.12% |
| 2021 Q4 | 68.15 Million USD | 1.24% |
| 2021 FY | - USD | 24.54% |
| 2021 Q2 | 62.85 Million USD | 50.15% |
| 2020 Q1 | 58.34 Million USD | 15.4% |
| 2020 Q3 | 70.65 Million USD | 50.29% |
| 2020 Q4 | 60.63 Million USD | -14.18% |
| 2020 FY | - USD | -6.38% |
| 2020 Q2 | 47 Million USD | -19.43% |
| 2019 Q2 | 60.77 Million USD | 40.51% |
| 2019 Q3 | 51.39 Million USD | -15.42% |
| 2019 Q4 | 50.55 Million USD | -1.64% |
| 2019 FY | - USD | 43.81% |
| 2019 Q1 | 43.25 Million USD | -0.95% |
| 2018 Q4 | 43.66 Million USD | 41.91% |
| 2018 Q2 | 57.14 Million USD | 71.65% |
| 2018 Q1 | 33.29 Million USD | 87.62% |
| 2018 FY | - USD | 114.52% |
| 2018 Q3 | 30.77 Million USD | -46.15% |
| 2017 Q2 | 35.77 Million USD | 20.9% |
| 2017 Q3 | 30.96 Million USD | -13.45% |
| 2017 Q4 | 17.74 Million USD | -42.7% |
| 2017 FY | - USD | -48.66% |
| 2017 Q1 | 29.59 Million USD | -34.92% |
| 2016 Q3 | 49.37 Million USD | 24.86% |
| 2016 Q4 | 45.47 Million USD | -7.9% |
| 2016 FY | - USD | 38.17% |
| 2016 Q2 | 39.54 Million USD | -0.24% |
| 2016 Q1 | 39.64 Million USD | 35.94% |
| 2015 Q4 | 29.15 Million USD | 97.45% |
| 2015 Q1 | 33.52 Million USD | 14.85% |
| 2015 Q2 | 16.14 Million USD | -51.83% |
| 2015 Q3 | 14.76 Million USD | -8.54% |
| 2015 FY | - USD | 21.71% |
| 2014 Q4 | 29.18 Million USD | 42.71% |
| 2014 Q3 | 20.45 Million USD | 31.51% |
| 2014 FY | - USD | -12.85% |
| 2014 Q1 | 23.07 Million USD | -20.82% |
| 2014 Q2 | 15.55 Million USD | -32.61% |
| 2013 Q2 | 20.59 Million USD | 693.37% |
| 2013 Q4 | 29.14 Million USD | 2.02% |
| 2013 FY | - USD | -4.37% |
| 2013 Q1 | 2.59 Million USD | -88.62% |
| 2013 Q3 | 28.56 Million USD | 38.71% |
| 2012 Q2 | 31.66 Million USD | 40.34% |
| 2012 Q3 | 33.15 Million USD | 4.68% |
| 2012 Q4 | 22.81 Million USD | -31.17% |
| 2012 FY | - USD | 29.23% |
| 2012 Q1 | 22.56 Million USD | 8.86% |
| 2011 Q3 | 31.29 Million USD | 38.36% |
| 2011 Q1 | 30.9 Million USD | -10.99% |
| 2011 Q2 | 22.62 Million USD | -26.8% |
| 2011 Q4 | 20.72 Million USD | -33.77% |
| 2011 FY | - USD | -48.0% |
| 2010 Q3 | 37.08 Million USD | 8.57% |
| 2010 Q1 | 32.13 Million USD | -20.6% |
| 2010 FY | - USD | -0.04% |
| 2010 Q4 | 34.72 Million USD | -6.37% |
| 2010 Q2 | 34.15 Million USD | 6.28% |
| 2009 Q4 | 40.47 Million USD | 19.07% |
| 2009 Q1 | 31.17 Million USD | -17.36% |
| 2009 Q2 | 32.5 Million USD | 4.27% |
| 2009 FY | - USD | 69.58% |
| 2009 Q3 | 33.99 Million USD | 4.57% |
| 2008 Q4 | 37.72 Million USD | 338.76% |
| 2008 FY | - USD | -10.83% |
| 2008 Q3 | -15.8 Million USD | -148.13% |
| 2008 Q2 | 32.82 Million USD | 22.9% |
| 2008 Q1 | 26.71 Million USD | 37.96% |
| 2007 FY | - USD | 11.1% |
| 2007 Q4 | 19.36 Million USD | -23.35% |
| 2007 Q3 | 25.25 Million USD | 4.07% |
| 2007 Q1 | 22.46 Million USD | -14.74% |
| 2007 Q2 | 24.27 Million USD | 8.03% |
| 2006 Q2 | 17.64 Million USD | 2.07% |
| 2006 Q3 | 20.94 Million USD | 18.72% |
| 2006 Q4 | 26.34 Million USD | 25.78% |
| 2006 FY | - USD | 17.37% |
| 2006 Q1 | 17.28 Million USD | -5.03% |
| 2005 FY | - USD | 116.5% |
| 2005 Q4 | 18.2 Million USD | -5.73% |
| 2005 Q1 | 16.27 Million USD | 11.57% |
| 2005 Q2 | 16.22 Million USD | -0.32% |
| 2005 Q3 | 19.31 Million USD | 19.06% |
| 2004 Q1 | 13.48 Million USD | 364.3% |
| 2004 Q4 | 14.58 Million USD | 251.07% |
| 2004 Q3 | -9.65 Million USD | -169.22% |
| 2004 Q2 | 13.94 Million USD | 3.4% |
| 2004 FY | - USD | 21.14% |
| 2003 Q1 | 9.35 Million USD | 14.67% |
| 2003 FY | - USD | 3.53% |
| 2003 Q4 | 15.76 Million USD | -140.2% |
| 2003 Q3 | 13.21 Million USD | 25.41% |
| 2003 Q2 | 10.35 Million USD | 12.41% |
| 2002 Q4 | 8.76 Million USD | 9.45% |
| 2002 FY | - USD | 72.91% |
| 2002 Q1 | 6.9 Million USD | 37.44% |
| 2002 Q2 | 7.13 Million USD | -22.94% |
| 2002 Q3 | 5.87 Million USD | 34.39% |
| 2001 FY | - USD | 170.34% |
| 2001 Q2 | 4.88 Million USD | -42.35% |
| 2001 Q3 | 3.73 Million USD | 11.93% |
| 2001 Q4 | 6.41 Million USD | 28.8% |
| 2001 Q1 | 5.92 Million USD | 144.55% |
| 2000 Q1 | 1.42 Million USD | -81.6% |
| 2000 Q3 | 614 Thousand USD | 24.49% |
| 2000 Q4 | -11.99 Million USD | -548.14% |
| 2000 FY | - USD | -46.32% |
| 2000 Q2 | 774 Thousand USD | -2.09% |
| 1999 Q1 | -3.2 Million USD | -156.67% |
| 1999 Q3 | -2.8 Million USD | 41.67% |
| 1999 Q4 | -1.5 Million USD | 46.43% |
| 1999 FY | - USD | 0.68% |
| 1999 Q2 | -4.8 Million USD | 37.66% |
| 1998 FY | - USD | 23.96% |
| 1998 Q3 | -3.1 Million USD | 32.0% |
| 1998 Q4 | -2.8 Million USD | 11.76% |
| 1998 Q1 | -3 Million USD | 69.91% |
| 1998 Q2 | -4 Million USD | -47.06% |
| 1997 Q2 | -2.1 Million USD | -13.04% |
| 1997 FY | - USD | -104.26% |
| 1997 Q4 | -10.8 Million USD | -289.66% |
| 1997 Q3 | -2.4 Million USD | -11.54% |
| 1997 Q1 | -1.8 Million USD | 8.0% |
| 1996 FY | - USD | -163.95% |
| 1996 Q1 | -1.5 Million USD | 0.0% |
| 1996 Q2 | -1.5 Million USD | -11.11% |
| 1996 Q3 | -2 Million USD | -30.0% |
| 1996 Q4 | -2.2 Million USD | 3.85% |
| 1995 Q4 | -1.7 Million USD | -109.78% |
| 1995 FY | - USD | 0.0% |
| 1995 Q3 | -1.1 Million USD | 700.0% |
| 1995 Q2 | 2.3 Million USD | 0.0% |
| 1995 Q1 | 2.3 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 2943.991% |
| Cerus Corporation | -26.53 Million USD | 1545.467% |
| OrthoPediatrics Corp. | -8.38 Million USD | 4676.65% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 3754.956% |
| Talis Biomedical Corporation | -66.04 Million USD | 680.769% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 2400.264% |
| Inogen, Inc. | -45.67 Million USD | 939.705% |
| Spectral AI, Inc. | -12.26 Million USD | 3228.111% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 904.246% |
| CVRx, Inc. | -38.73 Million USD | 1090.341% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 10972.137% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 3268.159% |
| Orthofix Medical Inc. | -86.98 Million USD | 540.96% |
| Venus Concept Inc. | -26.11 Million USD | 1568.881% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 870.668% |
| Bioventus Inc. | -23.07 Million USD | 1762.631% |
| BrainsWay Ltd. | -2.31 Million USD | 16697.534% |
| Envoy Medical, Inc. | -18.23 Million USD | 2203.131% |
| electroCore, Inc. | -17.76 Million USD | 2259.735% |
| IceCure Medical Ltd | -15.25 Million USD | 2614.712% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 870.977% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 2375.605% |
| MaxCyte, Inc. | -44.12 Million USD | 969.219% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 3362.755% |
| Nexalin Technology, Inc. | -5.69 Million USD | 6838.689% |
| PAVmed Inc | -75.74 Million USD | 606.415% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 813.511% |
| RxSight, Inc. | -41.03 Million USD | 1034.691% |
| Sight Sciences, Inc. | -49.41 Million USD | 876.22% |
| SI-BONE, Inc. | -34.44 Million USD | 1213.537% |
| TELA Bio, Inc. | -40.63 Million USD | 1043.984% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 757.945% |
| Treace Medical Concepts, Inc. | -39 Million USD | 1083.309% |
| LivaNova PLC | 39.01 Million USD | -883.107% |
| 908 Devices Inc. | -34.02 Million USD | 1227.315% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 446.833% |
| Nemaura Medical Inc. | -7.28 Million USD | 5363.702% |
| NeuroPace, Inc. | -22.83 Million USD | 1779.815% |
| LENSAR, Inc. | -8.71 Million USD | 4501.756% |
| Apyx Medical Corporation | -18.11 Million USD | 2217.762% |
| Cutera, Inc. | -136.56 Million USD | 380.877% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 11448.195% |
| BioSig Technologies, Inc. | -28.15 Million USD | 1462.541% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -15145.191% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 1927.476% |
| Axonics, Inc. | 7.77 Million USD | -4833.363% |
| Outset Medical, Inc. | -153.78 Million USD | 349.413% |
| IRIDEX Corporation | -7.44 Million USD | 5249.96% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 491.018% |
| IRadimed Corporation | 20.8 Million USD | -1744.025% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 4857.741% |
| INVO Bioscience, Inc. | -6.88 Million USD | 5675.112% |
| Telesis Bio, Inc. | -40.49 Million USD | 1047.248% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -945.803% |
| Varex Imaging Corporation | 67.2 Million USD | -470.787% |
| Quipt Home Medical Corp. | 44.07 Million USD | -770.343% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 3628.694% |
| Pulmonx Corporation | -55.09 Million USD | 796.234% |
| Dynatronics Corporation | -976 Thousand USD | 39399.78% |
| Modular Medical, Inc. | -17.1 Million USD | 2342.7% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 2748.043% |
| Semler Scientific, Inc. | 23.58 Million USD | -1526.05% |
| InMode Ltd. | 196.28 Million USD | -95.416% |
| Bruker Corporation | 599 Million USD | 35.965% |
| Cytosorbents Corporation | -28.81 Million USD | 1431.337% |
| DexCom, Inc. | 916.7 Million USD | 58.158% |
| Align Technology, Inc. | 799.03 Million USD | 51.996% |
| Viveve Medical, Inc. | -20.61 Million USD | 1960.45% |
| ZimVie Inc. | 91.07 Million USD | -321.167% |
| Movano Inc. | -29.12 Million USD | 1416.975% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 8801.658% |
| Nexalin Technology, Inc. | -5.69 Million USD | 6838.689% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 10972.137% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 297.049% |
| Profound Medical Corp. | -27.12 Million USD | 1514.16% |
| Insulet Corporation | 323.6 Million USD | -18.532% |
| enVVeno Medical Corporation | -25.01 Million USD | 1633.172% |
| Surmodics, Inc. | 1.18 Million USD | -32186.953% |
| iCAD, Inc. | -6.56 Million USD | 5942.635% |
| Nuwellis, Inc. | -16.35 Million USD | 2445.127% |
| Biotricity, Inc. | -8.82 Million USD | 4444.782% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 495.995% |
| Aethlon Medical, Inc. | -11.84 Million USD | 3337.11% |
| InspireMD, Inc. | -20.91 Million USD | 1934.293% |
| PAVmed Inc. | -75.74 Million USD | 606.415% |
| BIOLASE, Inc. | -15.13 Million USD | 2633.648% |
| Beyond Air, Inc. | -59.03 Million USD | 749.776% |
| FONAR Corporation | 28.25 Million USD | -1257.691% |
| AxoGen, Inc. | -13.32 Million USD | 2977.919% |
| Vivani Medical, Inc. | -26.6 Million USD | 1541.555% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -1462.972% |
| Inari Medical, Inc. | 7.11 Million USD | -5292.507% |
| UFP Technologies, Inc. | 72.74 Million USD | -427.293% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 11428.802% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 6330.821% |
| Tenon Medical, Inc. | -15.52 Million USD | 2570.176% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 2612.57% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 1024.803% |
| AdaptHealth Corp. | -171.09 Million USD | 324.19% |
| Sintx Technologies, Inc. | -6.6 Million USD | 5911.652% |
| NanoVibronix, Inc. | -3.43 Million USD | 11266.492% |
| Quanterix Corporation | -38.08 Million USD | 1107.06% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 3628.694% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -1278463.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 238.332% |
| TransMedics Group, Inc. | -7.6 Million USD | 5144.969% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 1862.32% |
| NeuroMetrix, Inc. | -7.09 Million USD | 5505.571% |
| Hyperfine, Inc. | -47.06 Million USD | 915.046% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 757.844% |
| Biomerica, Inc. | -5.99 Million USD | 6500.284% |
| Bone Biologics Corporation | 479.57 Thousand USD | -79881.525% |
| AVITA Medical, Inc. | -39.56 Million USD | 1069.398% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 4281.531% |
| Silk Road Medical, Inc | -45.08 Million USD | 950.863% |